Abbott Korea, exclusively owning Ganaton, will make direct marketing in the Korean market

Abbott Korea has acquired the selling rights of the indigestion treatment, Ganaton, and will conduct direct marketing in the Korean market.

According to the company on the 5^th, as the license agreement of Ganaton with JW Pharma has been expired, Abbott Korea has conducted direct marketing for the drug.

After the term end of the agreement, JW Pharma has changed the name of Ganaton to ‘Ganakhan...